Fmoc-D-Cys(Trt)-OPfp
Need Assistance?
  • US & Canada:
    +
  • UK: +

Fmoc-D-Cys(Trt)-OPfp

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Fluorinated Amino Acids
Catalog number
BAT-005306
CAS number
200395-72-8
Molecular Formula
C43H30F5NO4S
Molecular Weight
751.77
Fmoc-D-Cys(Trt)-OPfp
IUPAC Name
(2,3,4,5,6-pentafluorophenyl) (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-tritylsulfanylpropanoate
Synonyms
(2,3,4,5,6-pentafluorophenyl)(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-tritylsulfanylpropanoate; Pentafluorophenyl N-[(9H-fluoren-9-ylmethoxy)carbonyl]-S-trityl-L-cysteinate
Purity
≥ 95%
Density
1.360 g/cm3
Boiling Point
803.5 °C at 760 mmHg
Storage
Store at 2-8 °C
InChI
InChI=1S/C43H30F5NO4S/c44-35-36(45)38(47)40(39(48)37(35)46)53-41(50)34(49-42(51)52-24-33-31-22-12-10-20-29(31)30-21-11-13-23-32(30)33)25-54-43(26-14-4-1-5-15-26,27-16-6-2-7-17-27)28-18-8-3-9-19-28/h1-23,33-34H,24-25H2,(H,49,51)/t34-/m1/s1
InChI Key
FDAUCYDVXIPBDR-UUWRZZSWSA-N
Canonical SMILES
C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)SCC(C(=O)OC4=C(C(=C(C(=C4F)F)F)F)F)NC(=O)OCC5C6=CC=CC=C6C7=CC=CC=C57

Fmoc-D-Cys(Trt)-OPfp, a protected amino acid derivative, plays a pivotal role in peptide synthesis and bioconjugation. Here are four key applications of Fmoc-D-Cys(Trt)-OPfp:

Peptide Synthesis: Widely utilized in solid-phase peptide synthesis, Fmoc-D-Cys(Trt)-OPfp facilitates the incorporation of cysteine into peptide chains. The temporary protective Fmoc group enables the sequential addition of amino acids, while the Trityl group shields the thiol functionality, preventing undesired side reactions and ensuring the synthesis of high-purity peptides.

Bioconjugation: Fmoc-D-Cys(Trt)-OPfp finds its place in bioconjugation techniques, where it is employed to attach peptides to proteins, nanoparticles, or other biomolecules. The selectively deprotected thiol group of protected cysteine can be reacted with maleimide-containing molecules, enabling the precise generation of site-specific conjugates for various research and therapeutic purposes.

Structural Biology: Engaged in peptide-based structure-function studies, researchers use Fmoc-D-Cys(Trt)-OPfp strategically to design experiments. By placing cysteine residues strategically, researchers can promote the formation of disulfide bridges that stabilize the three-dimensional structure of peptides. This understanding is instrumental in deciphering protein folding, stability, and function at a molecular level.

Drug Development: In the realm of drug development, Fmoc-D-Cys(Trt)-OPfp plays a crucial role in creating peptide-based therapeutic agents and probes. Its integration into peptide libraries opens avenues for exploring novel bioactive sequences. Furthermore, the cysteine residue serves as a platform for further modifications, enhancing the pharmacokinetic properties of peptides and expanding the scope of drug development endeavors.

1. Protection of asparagine and glutamine during N alpha-Bpoc-based solid-phase peptide synthesis
R I Carey, H Huang, J L Wadsworth, C S Burrell Int J Pept Protein Res. 1996 Mar;47(3):209-13. doi: 10.1111/j.1399-3011.1996.tb01346.x.
In this paper we describe the synthesis and properties of Bpoc-Asn(Trt)-OH, Bpoc-Asn(Trt)-OPfp, Bpoc-Gln(Trt)-OH and Bpoc-Gln(Trt)-OPfp. These derivatives are highly soluble in CH2Cl2 and can be coupled efficiently in solid-phase peptide synthesis. The peptides, acetyl-Ala-Phe-Asn(Trt)-Gly-Leu-Ala-O-Dbf-SH and Boc-Cys(Acm)-Ala-Phe-Gln(Trt)-Gly-Leu-Ala-O-Dbf-SH (where O-Dbf-SH is the peptide ester of 4-mercapto-6-hydroxydibenzofuran) were synthesized by stepwise solid-phase peptide synthesis using N alpha-Bpoc amino acids. We have observed that less than 0.1% of the trityl group is removed from the carboxamide of Gln and Asn during a standard 15 min N alpha-Bpoc deprotection in 0.5% TFA in CH2Cl2.
2. Solid-phase synthesis of huwentoxin-I and its structure and bioactivity analysis
S Liang, Z Xia, J Xie Sci China C Life Sci. 1997 Oct;40(5):449-57. doi: 10.1007/BF03183581.
Huwentoxin-I, a neurotoxic peptide from the spiderSelenocosmia huwena, was synthesized by solid-phase method with Fluorenylmethoxycarbonyl amino acid pentafluorophenyl esters (Fmoc-AA-OPfp). The carboxyl and the hydroxy groups were protected by tBu; the side chains of Lys and His were protected by Boc; the guanidine group of Arg was protected by Mtr and the mercaptan group of Cys was protected by Trt. The solid-phase carrier was ethylene diamine-polyethylene-polystyrene (DEA-PEG-PS) resin. The synthetic peptide was cleaved from the resin and deprotected by a 90 % TFA solution containing 5 % thioanisole, 3% ethanedithiol and 2 % anisole. The product was reduced with DTT and then incubated with GSSG and GSH to form the correct disulfide bond linkages. The synthetic peptide was purified by HPLC and then characterized by amino acid composition and sequence analysis, peptide mapping and NMR. The biological activity of the synthetic product was tested by electrophysiological method using the isolated mouse phrenic nerve diaphragm preparation. The results indicated that the synthetic huwentoxin-I has the same chemical and conformational structure and biological activity as those of the native huwentoxin-I from the spider.
Online Inquiry
Verification code
Inquiry Basket